DOI: 10.3724/SP.J.1263.2011.00159

Journal of Geriatric Cardiology 2011/8:3 PP.159-167

Mitochondria and the aging heart

The average human life span has markedly increased in modern society largely attributed to advances in medical and therapeutic sciences that have successfully reduced important health risks. However, advanced age results in numerous alterations to cellular and subcellular components that can impact the overall health and function of an individual. Not surprisingly, advanced age is a major risk factor for the development of heart disease in which elderly populations observe increased morbidity and mortality. Even healthy individuals that appear to have normal heart function under resting conditions, actually have an increased susceptibility and vulnerability to stress. This is confounded by the impact that stress and disease can have over time to both the heart and vessels. Although, there is a rapidly growing body of literature investigating the effects of aging on the heart and how age-related alterations affect cardiac function, the biology of aging and underlying mechanisms remain unclear. In this review, we summarize effects of aging on the heart and discuss potential theories of cellular aging with special emphasis on mitochondrial dysfunction.

Key words:aging,heart,mitochondria,heart diseases,reactive oxygen species

ReleaseDate:2014-07-21 15:55:46

1 Statistics-Canada. Mortality, Summary List of Causes. 2007. (accessed on September 15, 2011).

2 Starnes JW, Bowles DK, Seiler KS. Myocardial injury after hypoxia in immature, adult and aged rats. Aging (Milano) 1997; 9: 268-276.

3 Lesnefsky EJ, Gallo DS, Ye J, et al. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med 1994; 124: 843-851.

4 Liu M, Zhang P, Chen M, et al. Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats. Age (Dordr) 2011; In press.

5 Mariani J, Ou R, Bailey M, et al. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg 2000; 120: 660-667.

6 Rosenfeldt FL, Pepe S, Ou R, et al. Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: studies in rats and in human atrial tissue. Biofactors 1999; 9: 291-299.

7 Abete P, Napoli C, Santoro G, et al. Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol 1999; 31: 227-236.

8 Jansen-Durr P, Osiewacz HD. Healthy ageing: a question of stress, damage and repair. Meeting on mechanisms of biological ageing. EMBO Rep 2002; 3: 1127-1132.

9 Misare BD, Krukenkamp IB, Levitsky S. Age-dependent sensitivity to unprotected cardiac ischemia: the senescent myocardium. J Thorac Cardiovasc Surg 1992; 103: 60-64.

10 Jugdutt BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev 2010; 15: 401-405.

11 Ahmed A. Chronic heart failure in older adults. Med Clin North Am 2011; 95: 439-461.

12 Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.

13 Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.

14 Wood P, Piran S, Liu PP. Diastolic heart failure: progress, treatment challenges, and prevention. Can J Cardiol 2011; 27: 302-310.

15 Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.

16 Shibata S, Hastings JL, Prasad A, et al. Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism. J Appl Physiol 2011; 110: 964-971.

17 Yang X, Sreejayan N, Ren J. Views from within and beyond: narratives of cardiac contractile dysfunction under senescence. Endocrine 2005; 26: 127-137.

18 Yang X, Doser TA, Fang CX, et al. Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. FASEB J 2006; 20: 1024-1026.

19 Shinmura K, Tamaki K, Sano M, et al. Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol 2011; 50: 117-127.

20 Ming Z, Legare DJ, Lautt WW. Absence of meal-induced insulin sensitization (AMIS) in aging rats is associated with cardiac dysfunction that is protected by antioxidants. J Appl Physiol 2011; In press.

21 Wierzbowska-Drabik K, Krzeminska-Pakula M, Chrzanowski L, et al. Age-dependency of classic and new parameters of diastolic function. Echocardiography 2008; 25: 149-155.

22 Sanders D, Dudley M, Groban L. Diastolic dysfunction, cardiovascular aging, and the anesthesiologist. Anesthesiol Clin 2009; 27: 497-517.

23 Fares E, Howlett SE. Effect of age on cardiac excitation-contraction coupling. Clin Exp Pharmacol Physiol 2010; 37: 1-7.

24 Onose Y, Oki T, Mishiro Y, et al. Influence of aging on systolic left ventricular wall motion velocities along the long and short axes in clinically normal patients determined by pulsed tissue doppler imaging. J Am Soc Echocardiogr 1999; 12: 921-926.

25 Bujak M, Kweon HJ, Chatila K, et al. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol 2008; 51: 1384-1392.

26 Slotwiner DJ, Devereux RB, Schwartz JE, et al. Relation of age to left ventricular function in clinically normal adults. Am J Cardiol 1998; 82: 621-626.

27 Shannon RP, Maher KA, Santinga JT, et al. Comparison of differences in the hemodynamic response to passive postural stress in healthy subjects greater than 70 years and less than 30 years of age. Am J Cardiol 1991; 67: 1110-1116.

28 Fleg JL, O'Connor F, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995; 78: 890-900.

29 Ahmet I, Tae HJ, de Cabo R, et al. Effects of calorie restriction on cardioprotection and cardiovascular health. J Mol Cell Cardiol 2011; 51: 263-271.

30 Reddy AK, Amador-Noguez D, Darlington GJ, et al. Cardiac function in young and old Little mice. J Gerontol A Biol Sci Med Sci 2007; 62: 1319-1325.

31 Boyle AJ, Shih H, Hwang J, et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 2011; 46: 549-559.

32 De Meersman RE. Heart rate variability and aerobic fitness. Am Heart J 1993; 125: 726-731.

33 Carter JB, Banister EW, Blaber AP. The effect of age and gender on heart rate variability after endurance training. Med Sci Sports Exerc 2003; 35: 1333-1340.

34 Romanowicz M, Schmidt JE, Bostwick JM, et al. Changes in heart rate variability associated with acute alcohol consumption: current knowledge and implications for practice and research. Alcohol Clin Exp Res 2011; 35: 1092-1105.

35 Xiao RP, Spurgeon HA, O'Connor F, et al. Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest 1994; 94: 2051-2059.

36 Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2009; 2: 191-198.

37 Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-1568.

38 Olivetti G, Cigola E, Maestri R, et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 1996; 28: 1463-1477.

39 Melissari M, Balbi T, Gennari M, et al. The aging of the heart: weight and structural changes in the left ventricle with age. G Ital Cardiol 1991; 21: 119-130.

40 Linzbach AJ, Akuamoa-Boateng E. Changes in the aging human heart. I. Heart weight in the aged. Klin Wochenschr 1973; 51: 156-163.

41 Hees PS, Fleg JL, Lakatta EG, et al. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol 2002; 90: 1231-1236.

42 Sangaralingham SJ, Huntley BK, Martin FL, et al. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide. Hypertension 2011; 57: 201-207.

43 Burlew BS, Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 2000; 18: 435-442.

44 Kajstura J, Urbanek K, Perl S, et al. Cardiomyogenesis in the adult human heart. Circ Res 107: 305-315.

45 Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.

46 Fares E, Howlett SE. Effect of age on cardiac excitation-contraction coupling. Clin Exp Pharmacol Physiol 2010; 37: 1-7.

47 Jovanovic S, Jovanovic A. Sarcolemmal K(ATP) channels in ageing. Ageing Res Rev 2004; 3: 199-214.

48 Ranki HJ, Crawford RM, Budas GR, et al. Ageing is associated with a decrease in the number of sarcolemmal ATP-sensitive K+ channels in a gender-dependent manner. Mech Ageing Dev 2002; 123: 695-705.

49 Raveaud S, Verdetti J, Faury G. Nicorandil protects ATP-sensitive potassium channels against oxidation-induced dysfunction in cardiomyocytes of aging rats. Biogerontology 2009; 10: 537-547.

50 Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006; 125: 1241-1252.

51 Hafner AV, Dai J, Gomes AP, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY)2010; 2: 914-923.

52 Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc 1972; 20: 145-147.

53 Miquel J, Economos AC, Fleming J, et al. Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-591.

54 Linnane AW, Marzuki S, Ozawa T, et al. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989; 1: 642-645.

55 Gottlieb RA, Gustafsson AB. Mitochondrial turnover in the heart. Biochim Biophys Acta 2011; 1813: 1295-1301.

56 Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA 2005; 102: 5618-5623.

57 Boffoli D, Scacco SC, Vergari R, et al. Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994; 1226: 73-82.

58 Frenzel H, Feimann J. Age-dependent structural changes in the myocardium of rats: A quantitative light- and electron-microscopic study on the right and left chamber wall. Mech Ageing Dev 1984; 27: 29-41.

59 Desler C, Marcker ML, Singh KK, et al. The importance of mitochondrial DNA in aging and cancer. J Aging Res 2011; 407536.

60 Chen L, Gong Q, Stice JP, et al. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009; 84: 91-99.

61 Raffaello A, Rizzuto R. Mitochondrial longevity pathways. Biochim Biophys Acta 2011; 1813: 260-268.

62 Sagan L. On the origin of mitosing cells. J Theor Biol 1967; 14: 255-274.

63 Margulis L. Symbiotic theory of the origin of eukaryotic organelles; criteria for proof. Symp Soc Exp Biol 1975; (29): 21-38.

64 Margulis L. Recombination of non-chromosomal genes in Chlamydomonas: assortment of mitochondria and chloroplasts? J Theor Biol 1970; 26: 337-342.

65 Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120: 483-495.

66 Hom J, Sheu SS Morphological dynamics of mitochondria—A special emphasis on cardiac muscle cells. J Mol Cell Cardiol 2009; 46: 811-820.

67 Vendelbo MH, Nair KS. Mitochondrial longevity pathways. Biochim Biophys Acta 2011; 1813: 634-644.

68 Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628-632.

69 Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 2010; 51: 440-450.

70 Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.

71 Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988; 85: 6465-6467.

72 Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-519.

73 Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet 1995; 29: 151-178.

74 Fayet G, Jansson M, Sternberg D, et al. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromuscul Disord 2002; 12: 484-493.

75 Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, et al. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease. Ann NY Acad Sci 2008; 1147: 1-20.

76 Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17: 171-184.

77 Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.

78 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.

79 Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309-313.

80 Sun J, Folk D, Bradley TJ, et al. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 2002; 161: 661-672.

81 Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308: 1909-1911.

82 Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11: 376-381.

83 Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 9782-9787.

84 Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 2000; 275: 3343-3347.

85 Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989; 1: 637-639.

86 Alexeyev MF, Ledoux SP, Wilson GL. Mitochondrial DNA and aging. Clin Sci (Lond) 2004; 107: 355-364.

87 Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1998; 1366: 53-67.

88 Trifunovic A, Hansson A, Wredenberg A, et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 2005; 102: 17993-17998.

89 Di Lisa F, Bernardi P. Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res 2005; 66: 222-232.

90 Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 91: 10771-10778.

91 Grivennikova VG, Kareyeva AV, Vinogradov AD. What are the sources of hydrogen peroxide production by heart mitochondria? Biochim Biophys Acta 2010; 1797: 939-944.

92 Desler C, Lykke A, Rasmussen LJ. The effect of mitochondrial dysfunction on cytosolic nucleotide metabolism. J Nucleic Acids 2010; 701518.

93 Desler C, Munch-Petersen B, Stevnsner T, et al. Mitochondria as determinant of nucleotide pools and chromosomal stability. Mutat Res 2007; 625: 112-124.

94 Brady NR, Hamacher-Brady A, Westerhoff HV, et al. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal 2006; 8: 1651-1665.

95 Ussher JR, Lopaschuk GD. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res 2008; 79: 259-268.

96 Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-477.

97 Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.

98 Simonsen A, Cumming RC, Brech A, et al. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008; 4: 176-184.

99 Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441: 885-889.

100 Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441: 880-884.

101 Cuervo AM, Dice JF. How do intracellular proteolytic systems change with age? Front Biosci 1998; 3: D25-D43.

102 Cuervo AM, Bergamini E, Brunk UT, et al. Autophagy and aging: the importance of maintaining “clean” cells. Autophagy 2005; 1: 131-140.

103 Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89: 799-845.

104 Twig G, Elorza A, Molina AJA, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008; 27: 433-446.

105 Bratic I, Trifunovic A. Mitochondrial energy metabolism and ageing. Biochim Biophys Acta 2010; 1797: 961-967.

106 Gottlieb RA, Carreira RS. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010; 299: C203-C210.